Weapon | Jotup

ROBLOX ALERT: Bragar Eagel & Squire, P.C. is Investigating Roblox Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Retrieved on:

Wednesday, March 20, 2024

Roblox Corporation, RBLX, COVID, Growth, Weapon, Telephone, Defendant, Class, Complaint, P.C, Parent, Video game

Our investigation concerns whether the board of directors of Roblox have breached their fiduciary duties to the company.

Key Points:

Our investigation concerns whether the board of directors of Roblox have breached their fiduciary duties to the company.
Roblox operates a platform that provides developers with tools to create online games and hosts the games on its servers.
The Complaint alleges that throughout the Class Period, Roblox reported strong bookings and revenue growth.
On February 15, 2022, the truth about the Company’s unsustainable growth was revealed to investors when Roblox reported surprisingly weak fourth quarter 2021 results.

Lilith Games Celebrates Three-Year Anniversary of Military RTS MMO Warpath with In-Game Events and Rewards

Retrieved on:

Tuesday, March 19, 2024

Reticle, Weapon, MMO, Google Play, City, App Store (iOS/iPadOS), Hold Your Breath, Skin, Telescopic sight

SHANGHAI, China, March 19, 2024 (GLOBE NEWSWIRE) -- Lilith Games — the acclaimed studio behind AFK Arena, Rise of Kingdoms, and Dislyte — has announced third-anniversary celebrations for its widely acclaimed real-time military strategy MMO, Warpath .

Key Points:

SHANGHAI, China, March 19, 2024 (GLOBE NEWSWIRE) -- Lilith Games — the acclaimed studio behind AFK Arena, Rise of Kingdoms, and Dislyte — has announced third-anniversary celebrations for its widely acclaimed real-time military strategy MMO, Warpath .
Warpath has also been crowned the Best Selling Strategy Game in 16 countries on the Google Play Store and 47 countries on the App Store.
To celebrate three years of Warpath, Lilith Games has launched a care package chock full of minigames and prizes.
Warpath’s three-year anniversary celebration contains 15 new events for fans to take part in and a payload of prizes to unlock.

Evolv Technologies (EVLV) Crashes After Disclosing SEC Investigation - Hagens Berman

Retrieved on:

Monday, March 18, 2024

Weapon, Intelligence, SAN, Knowledge, Person, News, Stabbing, Upstate New York, Hagens Berman, Marketing, Life insurance

SAN FRANCISCO, March 18, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) investors who suffered substantial losses to submit your losses now .

Key Points:

SAN FRANCISCO, March 18, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) investors who suffered substantial losses to submit your losses now .
News of the SEC investigation caused Evolv shares to drop 19% in one trading day.
“We are investigating whether Evolv may have deceived investors about the capabilities and effectiveness of Evolv’s technology,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation.
If you invested in Evolv Technologies and have substantial losses, or have knowledge that may assist the firm’s investigation, contact Hagens Berman now »
If you’d like more information and answers to frequently asked questions about the Evolv Technologies investigation, read more »
Whistleblowers: Persons with non-public information regarding Evolv Technologies should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.

Researchers Publish Manuscript on the Prevention and Emergency Response to Tularemia Outbreaks

Retrieved on:

Tuesday, March 12, 2024

Infection, Risk, Pharming, United Nations, Manuscript, Weapon, Outline of health sciences, TSX, Therapy, Siege, Drug development, Literature, Safety, Frontiers, Tularemia, FDA, Physician, Vaccine

Appili’s Director of Non-Clinical Research, Dr. Carl Gelhaus, Ph.D., together with medical doctors from the United States Uniformed Services University of the Health Sciences and Ukrainian researchers published a perspective manuscript “ Considerations for prevention of and emergency response to tularemia outbreaks in Ukraine: vaccine involvement ”.

Key Points:

Appili’s Director of Non-Clinical Research, Dr. Carl Gelhaus, Ph.D., together with medical doctors from the United States Uniformed Services University of the Health Sciences and Ukrainian researchers published a perspective manuscript “ Considerations for prevention of and emergency response to tularemia outbreaks in Ukraine: vaccine involvement ”.
“Appili has been developing ATI-1701 , a biodefense vaccine, to protect warfighters from tularemia.” said Carl Gelhaus, Ph.D., Director of Non-Clinical Research of Appili Therapeutics.
“With the help of our Ukrainian colleagues and U.S. Army physicians, we have assessed the potential risk for tularemia outbreaks in Ukraine, by reviewing the literature of previous wartime outbreaks in Eastern Europe.
Many of the conditions for tularemia outbreaks now exist in Ukraine, and their warfighters need protection.

The Lord of the Rings: Return to Moria™ Launches Alpha Version of Sandbox Mode – Available Today

Retrieved on:

Thursday, April 4, 2024

Tolkien, now includes an Alpha version of Sandbox Mode on the PC.

Key Points:

Tolkien, now includes an Alpha version of Sandbox Mode on the PC.
This update for The Lord of the Rings: Return to Moria also includes various UI updates and features and other improvements.
View the full release here: https://www.businesswire.com/news/home/20240404581717/en/
Watch a walkthrough of the new Game Update for The Lord of the Rings: Return to Moria on YouTube.
Sandbox Mode: Players who wish to explore Moria more freely can now experience the Alpha version of Sandbox Mode!

EVLV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Retrieved on:

Tuesday, April 2, 2024

Class Action Lawsuit, Professional Services, Legal, Gun, Firearm, Weapon, Risk, School, Complaint, Court, Work, Artificial intelligence, Violence, Person, Security (finance)

Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/EVLV .

Key Points:

Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/EVLV .
According to the Complaint, Evolv describes itself as a “leader in Artificial Intelligence ('AI')-based weapons detection for security screening.
or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Evolv Technologies Holdings, Inc. (EVLV)

Retrieved on:

Monday, April 1, 2024

Class Action Lawsuit, Professional Services, Legal, Gun, IPVM, Weapon, Risk, GPM, School, Defendant, NPSA, BBC News, News, Suite, Security, Bomb, BBC, Court, Cryptocurrency

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points:

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
On this news, Evolv’s stock price fell $0.08, or 2.7%, to close at $2.85 per share on November 2, 2022, thereby injuring investors.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Evolv Technologies Holdings, Inc. (EVLV) Stockholder Alert: Robbins LLP Reminds Investors of Evolv Technologies Holdings, Inc. f/k/a Newhold Investment Corp. Class Action

Retrieved on:

Sunday, March 31, 2024

Class Action Lawsuit, Professional Services, Legal, Gun, Weapon, Risk, School, Light, LLP, Efficacy, Complaint, Artificial intelligence, Person

Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) securities between June 28, 2021 and March 13, 2024.

Key Points:

Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) securities between June 28, 2021 and March 13, 2024.
Evolv describes itself as a “leader in Artificial Intelligence (“AI”)-based weapons detection for security screening."
For more information, submit a form , email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
The Allegations: Robbins LLP is Investigating the Allegations that Evolv Technologies Holdings, Inc. (EVLV) Overstated the Efficacy of its Products
On or around July 19, 2021, Evolv went public through a SPAC merger with Newhold Investment Corp.

EVLV INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Retrieved on:

Saturday, March 30, 2024

Class Action Lawsuit, Professional Services, Legal, Gun, IPVM, Weapon, Risk, School, BBC News, News, Acquisition, AI, Complaint, BBC, Marketing, Artificial intelligence

), the Evolv class action lawsuit charges Evolv and certain of Evolv’s top current and former executives with violations of the Securities Exchange Act of 1934.

Key Points:

), the Evolv class action lawsuit charges Evolv and certain of Evolv’s top current and former executives with violations of the Securities Exchange Act of 1934.
Lead plaintiff motions for the Evolv class action lawsuit must be filed with the court no later than May 24, 2024.
A lead plaintiff acts on behalf of all other class members in directing the Evolv class action lawsuit.
An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Evolv class action lawsuit.

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Evolv Technologies Holdings, Inc. (EVLV)

Retrieved on:

Friday, March 29, 2024

Class Action Lawsuit, Professional Services, Legal, Gun, Law, IPVM, Weapon, Risk, Telephone, School, Defendant, NPSA, BBC News, News, Suite, Security, Bomb, BBC, Court, Cryptocurrency

Investors suffering losses on their Evolv investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at (215) 638-4847 or by email to [email protected] .

Key Points:

Investors suffering losses on their Evolv investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at (215) 638-4847 or by email to [email protected] .
On this news, Evolv’s stock price fell $0.08, or 2.7%, to close at $2.85 per share on November 2, 2022, thereby injuring investors.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.